Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMNICELL, INC.OMCL · Entity 4666 | EVP, Global R & D | March 11, 2019 | March 12, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMNICELL, INC.
Report date March 11, 2019 · Filed March 12, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,952 |
Reported balance
After 2019-03-11 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2019-03-11 · Exercise / conversion · Acquired 9,796 · Balance 45,952 |
| Common StockSEC Table I · non-derivative | Direct | 36,156 |
Reported balance
After 2019-03-11 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2019-03-11 · Sale · Disposed 9,796 · Balance 36,156 F1: The price reported in Column 4 is the average price of $83.9365. The sold price range between $83.60 to $84.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 35,024 |
Reported balance
After 2019-03-12 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2019-03-12 · Sale · Disposed 1,132 · Balance 35,024 F2: The price reported in Column 4 is the exact price of $83.6763. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 43,892 |
Reported balance
After 2019-03-12 transaction · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · 2019-03-12 · Exercise / conversion · Acquired 8,868 · Balance 43,892 |
| Common StockSEC Table I · non-derivative | Direct | 35,024 |
Reported balance
After 2019-03-12 transaction · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · 2019-03-12 · Sale · Disposed 8,868 · Balance 35,024 F3: The price reported in Column 4 is the average price of $83.7880. The sold price range between $83.25 to $84.02. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 36,156 |
Reported balance
Holding disclosure · report date 2019-03-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 36,156 |
| Stock Options NQ (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.70 · Expires 2027-02-07 | Direct | 0 |
Reported balance
After 2019-03-11 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-11 · Exercise / conversion · Disposed 4,088 · Balance 0 |
| Stock Options NQ (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4,536.00 · Expires 2026-02-03 | Direct | 0 |
Reported balance
After 2019-03-11 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-03-11 · Exercise / conversion · Disposed 4,536 · Balance 0 |
| Stock Options NQ (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.02 · Expires 2025-02-05 | Direct | 0 |
Reported balance
After 2019-03-11 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2019-03-11 · Exercise / conversion · Disposed 1,172 · Balance 0 |
| Stock Options NQ (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.70 · Expires 2026-02-03 | Direct | 0 |
Reported balance
After 2019-03-12 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2019-03-12 · Exercise / conversion · Disposed 908 · Balance 0 |
| Stock Options NQ (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.70 · Expires 2027-02-07 | Direct | 0 |
Reported balance
After 2019-03-12 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2019-03-12 · Exercise / conversion · Disposed 628 · Balance 0 |
| Stock Options NQ (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $44.25 · Expires 2028-02-05 | Direct | 0 |
Reported balance
After 2019-03-12 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2019-03-12 · Exercise / conversion · Disposed 7,332 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is the average price of $83.9365. The sold price range between $83.60 to $84.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in Column 4 is the exact price of $83.6763. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is the average price of $83.7880. The sold price range between $83.25 to $84.02. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to buy) · Derivative | 7,332 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001179110-19-003768 · edgar.xml · derivative · entry 12 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,332 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to buy) · Derivative | 628 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-19-003768 · edgar.xml · derivative · entry 11 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 628 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to buy) · Derivative | 908 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-003768 · edgar.xml · derivative · entry 10 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 908 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 8,868 | $83.79 | $743,031.98 |
DisclosureSEC source: 0001179110-19-003768 · edgar.xml · nonDerivative · entry 6 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,024 F3 · price: The price reported in Column 4 is the average price of $83.7880. The sold price range between $83.25 to $84.02. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 8,868 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003768 · edgar.xml · nonDerivative · entry 5 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,132 | $83.68 | $94,721.57 |
DisclosureSEC source: 0001179110-19-003768 · edgar.xml · nonDerivative · entry 4 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,024 F2 · price: The price reported in Column 4 is the exact price of $83.6763. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to buy) · Derivative | 1,172 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-19-003768 · edgar.xml · derivative · entry 9 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,172 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to buy) · Derivative | 4,536 | $0.00 Strike: $4,536.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003768 · edgar.xml · derivative · entry 8 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,536 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to buy) · Derivative | 4,088 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-19-003768 · edgar.xml · derivative · entry 7 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,088 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 9,796 | $83.94 | $822,241.95 |
DisclosureSEC source: 0001179110-19-003768 · edgar.xml · nonDerivative · entry 3 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,156 F1 · price: The price reported in Column 4 is the average price of $83.9365. The sold price range between $83.60 to $84.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 9,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003768 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 00:27 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 597 | $84.27 | $50,309.19 |
DisclosureSEC source: 0001179110-19-003478 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,156 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 01, 2019 Filed Feb 1, 2019 22:55 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 132 | $64.09 | $8,459.64 |
DisclosureSEC source: 0001179110-19-001180 · edgar.xml · nonDerivative · entry 6 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,753 F5 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $64.0882. The sold price range between $64.02 to $64.11. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2019 Filed Feb 1, 2019 22:55 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 786 | $64.25 | $50,498.30 |
DisclosureSEC source: 0001179110-19-001180 · edgar.xml · nonDerivative · entry 5 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,885 F5 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4 is the average price of $64.2472. The sold price range between $64.00 to $64.43. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2019 Filed Feb 1, 2019 22:55 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 645 | $64.24 | $41,435.19 |
DisclosureSEC source: 0001179110-19-001180 · edgar.xml · nonDerivative · entry 4 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,671 F5 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $64.2406. The sold price range between $64.09 to $64.43. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2019 Filed Feb 1, 2019 22:55 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 683 | $64.25 | $43,880.63 |
DisclosureSEC source: 0001179110-19-001180 · edgar.xml · nonDerivative · entry 3 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,316 F5 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $64.2469. The sold price range between $64.15 to $64.39. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2019 Filed Feb 1, 2019 22:55 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 263 | $64.50 | $16,963.50 |
DisclosureSEC source: 0001179110-19-001180 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,999 F5 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| December 15, 2018 Filed Dec 17, 2018 22:46 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 899 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-013979 · edgar.xml · nonDerivative · entry 3 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,262 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| December 15, 2018 Filed Dec 17, 2018 22:46 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 1,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-013979 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,161 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 7,859 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · derivative · entry 10 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,859 Underlying: Common Stock · 7,859 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 6,532 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · derivative · entry 9 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,532 Underlying: Common Stock · 6,532 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 888 | $58.71 | $52,136.97 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 8 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,720 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F7 · price: The price reported in Column 4 is the average price of $58.7128. The sold price range was $58.15 to $59.70. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 837 | $59.02 | $49,398.15 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 7 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,608 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F6 · price: The price reported in Column 4 is the average price of $59.0181. The sold price range was $58.20 to $59.675. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 738 | $58.70 | $43,320.01 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 6 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,445 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · price: The price reported in Column 4 is the average price of $58.6992. The sold price range was $58.15 to $59.675. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 790 | $58.98 | $46,597.52 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 5 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,183 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $58.9842. The sold price range was $58.10 to $59.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 7,859 | $58.76 | $461,776.76 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 4 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,973 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4 is the average price of $58.7577. The sold price range was $58.05 to $59.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 6,532 | $58.76 | $383,796.15 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 3 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,832 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $58.7563. The sold price range was $58.05 to $59.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 14,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,563 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-18-009727 · edgar.xml · derivative · entry 7 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,563 Underlying: Common Stock · 1,563 shares Expires 2025-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,641 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-18-009727 · edgar.xml · derivative · entry 6 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,641 Underlying: Common Stock · 1,641 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,421 | $0.00 Strike: $13.67 | $0.00 |
DisclosureSEC source: 0001179110-18-009727 · edgar.xml · derivative · entry 5 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,421 Underlying: Common Stock · 1,421 shares Expires 2022-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 6,957 | $52.98 | $368,602.73 |
DisclosureSEC source: 0001179110-18-009727 · edgar.xml · nonDerivative · entry 4 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,973 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4 is the average price of $52.9830. The sold price range was between $52.70 to $53.75. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 4,625 | $52.99 | $245,095.40 |
DisclosureSEC source: 0001179110-18-009727 · edgar.xml · nonDerivative · entry 3 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,930 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $52.9936. The sold price range was between $52.70 to $53.75. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 4,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009727 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:19 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 1,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008712 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,930 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 23:18 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 972 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003799 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,640 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 17:45 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantStock Option (right to Buy) · Derivative | 27,072 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001179110-18-001768 · edgar.xml · derivative · entry 4 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,072 Underlying: Common Stock · 27,072 shares Expires 2028-02-06 F2 · shares: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 17:45 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 6,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001768 · edgar.xml · nonDerivative · entry 3 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,612 F3 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2019 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2019 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 17:45 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 6,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001768 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,694 F1 · shares: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:28 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 739 | $51.75 | $38,243.25 |
DisclosureSEC source: 0001179110-17-015489 · edgar.xml · nonDerivative · entry 3 Taborga Jorge R. · CIK 0001571822 · Executive VP. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,592 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:28 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 1,387 | $51.75 | $71,777.25 |
DisclosureSEC source: 0001179110-17-015489 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · Executive VP. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,331 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| November 06, 2017 Filed Nov 6, 2017 22:41 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 6,295 | $48.69 | $306,484.67 |
DisclosureSEC source: 0001179110-17-013786 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · Executive VP. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,718 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $48.6870. The shares sold between $48.35 to $48.95. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 20:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $18.55 | $0.00 |
DisclosureSEC source: 0001179110-17-011226 · edgar.xml · derivative · entry 9 Taborga Jorge R. · CIK 0001571822 · Executive VP. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2023-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 20:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 1,362 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-17-011226 · edgar.xml · derivative · entry 8 Taborga Jorge R. · CIK 0001571822 · Executive VP. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,362 Underlying: Common Stock · 1,362 shares Expires 2026-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 20:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 6,803 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-17-011226 · edgar.xml · derivative · entry 7 Taborga Jorge R. · CIK 0001571822 · Executive VP. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,803 Underlying: Common Stock · 6,803 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 20:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 3,515 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-17-011226 · edgar.xml · derivative · entry 6 Taborga Jorge R. · CIK 0001571822 · Executive VP. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,515 Underlying: Common Stock · 3,515 shares Expires 2025-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 20:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 3,282 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-17-011226 · edgar.xml · derivative · entry 5 Taborga Jorge R. · CIK 0001571822 · Executive VP. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,282 Underlying: Common Stock · 3,282 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 20:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 17,462 | $51.02 | $890,851.87 |
DisclosureSEC source: 0001179110-17-011226 · edgar.xml · nonDerivative · entry 4 Taborga Jorge R. · CIK 0001571822 · Executive VP. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,013 F1 · price: The price reported in Column 4 is the average price of $51.0166. The shares sold between $50.50 to $51.125. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 20:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 17,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011226 · edgar.xml · nonDerivative · entry 3 Taborga Jorge R. · CIK 0001571822 · Executive VP. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 20:08 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 3,257 | $50.80 | $165,455.60 |
DisclosureSEC source: 0001179110-17-011226 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · Executive VP. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,013 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the exact price of $50.80. All the shares sold for the exact price. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.